Cytokinetics (CYTK) Q1 2024 Earnings

27FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.38
-1.17
-0.97
-0.76

Details

Expected EPS
-0.96
Actual EPS
-1.38
Surprise EPS
-0.42
Surprise Percent
+43.75%

Description

Cytokinetics (CYTK) has reported earnings of -1.38 per share for Q1 2024.

0 Comments

Share your thoughts